logo
Plus   Neg
Share
Email
Comment

Achieve Life Sciences (ACHV) Is Spiking Higher After Partnership Expands

Achieve Life Sciences (ACHV) announced Wednesday morning that it has agreed to amend its Technology Licence Agreement with the University of Bristol. The company has been granted exclusive rights for all human medicinal uses of cytisine derivatives created under the agreement.

Achieve Life Sciences has spiked sharply to the upside in early trade Wednesday and is currently higher by 1.20 at $2.71 on above average volume. The stock has surged to a 3-month high.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

comments powered by Disqus
Follow RTT